Institute for Cancer Research and Treatment at Candiolo
The Institute for Cancer Research is a private non-profit institution founded by the Fondazione Piemontese per la Ricerca sul Cancro-Onlus (FPRC) and operated by the Fondazione del Piemonte per l'Oncologia (FPO: a joint venture between the FPRC and the Regione Piemonte). It is the seat of the Department of Oncological Sciences of the University of Torino. Its mission is to make a significant contribution to fight cancer by understanding the basics, and by providing optimal diagnostic and therapeutic services. Both basic research and clinical research are actively performed, placing the Institute at the interface between molecular biology and medicine. The FPRC provides enduring fund raising to complete and develop the Institute's buildings and technologies to support basic research.
"Molecular Clinical Oncology" is a novel discipline translating biology into medicine. Targeting single genetic lesions can interfere with tumor growth notwithstanding the multitude of genetic alterations harbored by cancers. This has given an unprecedented clinical value to the concept that cancer is a disease of genes, a dogma in molecular oncology that is now practically exploited by clinicians to set up novel classifications of tumors based on the presence of defined genetic lesions. Thanks to these advances, the idea of giving a patient a drug tailored to the genetic makeup of the tumor is becoming commonplace.